LS-4

N/A

Report date: 2025/01/26 18:25:05
NME

Base Information

Drug NameLS-4
Drug Alias Namebeta-amyloid/tau modulator (University of Illinois at Urbana-Champaign)LS-4
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta amyloid A4 protein modulatorsMicrotubule-associated protein tau modulators
TargetsMicrotubule-associated protein tauBeta amyloid A4 protein
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Illinois At Urbana–Champaign
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Illinois At Urbana–Champaign
Inactive CompaniesN/A
Active IndicationsAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A